2009 Archived NewsNovember
Cornell startup Metabolon aims to launch a diagnostics business during the next 12-18 months. Metabolon has identified several biomarkers and owns the necessary IP or has patent applications covering both prostate cancer and insulin resistance.
This may signal that the MEMS industry will undergo a new wave of consolidation to get into the MEMS industry as it enters in the mainstream markets.
Cornell startup Widetronix develops long-lived nuclear batteries powered by hydrogen isotopes for use in implantable medical devices.
A new center may help make such Cornell agricultural advances as transgenic drought- and salt-tolerant rice available in China.
Cornell startup, iFyber, uses technology developed through a cross-campus collaboration by fiber science professor Juan Hinestroza and Aaron Strickland, a research associate in the Department of Food Science.
Cornell startup, Jodange, offers a service geared toward online publishers that lets them incorporate opinion data drawn from over 450,000 sources, including mainstream news sources, blogs and Twitter.
The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein, a cancer vaccine that will be used in clinical trials for patients facing either ovarian cancer or melanoma.
Jim Mahoney, Novomer CEO, says the funding gives the company the cash it needs to ramp up its production process, buy raw materials, and design new products in conjunction with partners.
Cornell's Materials Science and Engineering Department, the Birck Nanotechnology Center, and the Center for Materials Research at Norfolk State have created a nanolaser.
Cornell startup, Pacific BioSciences, one of the companies working to advance DNA sequencing technology, brought in $68M in new financing.
Cornell Vice Provost, Alan Paau, was received by official of the Hainan Chengjiang Li Minority Autonomous Region in Hainan Island to explore collaboration opportunities in sustainable development for the area. Hainan Island is the second largest island in China. The island is the largest island of the Nansha (Spratly) and the Xisha (Paracel) archipelagos in South China Sea that represent the southern-most province of the country.
Chinese Minister of Agriculture, Sun Zhencai, received Cornell Vice Provost, Alan Paau, at the Chinese Ministry of Agriculture in Beijing, China to explore collaboration opportunities in agriculture technology development and commercialization.
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials to targeted cells in the bloodstream.
Cornell startup, Widetronix, beats 76 companies to win $100,000 cash prize.
Research at Cornell University could lead to low-power, high-efficiency memory chips.
A newly discovered gene fusion may lead to more accurate tests for prostate cancer.
A new method developed by Cornell biological engineers offers an efficient way to make proteins for use in medicine or industry without the use of live cells.
A novel device developed by Cornell researchers has a geometry that allows it to manipulate nanoparticles by size.
Researchers at Weill Cornell Medical College have identified a new marker for breast cancer metastasis called TMEM, for Tumor Microenvironment of Metastasis.
Cornell fiber scientist C.C. Chu and his collaborators develop a high-functioning artificial artery that the human body will accept as its own.
Physicians and scientists from New York-Presbyterian Hospital/Weill Cornell Medical College and the Ithaca campus may have developed a way to create engineered tissue that is well accepted by the body.
Studies by Rui Hai Liu support growing evidence that apple phytochemicals inhibit the growth of mammary tumors.
Cornell and Sun World operate two of the world's leading fresh grape breeding programs.